Rhizarthrosis: Autologous Stromal Vascular Fraction Injection

We are studying the safety and effects of an injection using your own stem cells for treating rhizarthrosis. This trial will help us understand its impact on pain and joint function over several months.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Autologous Adipose Tissue-Derived Stromal Vascular Fraction

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre Hospitalier Universitaire De Caen Normandie
Department of Orthopaedic Surgery and Traumatology
Caen, France
Centre Hospitalier Universitaire Amiens Picardie
Department of Orthopaedic Surgery and Traumatology
Colomiers, France
Centre Hospitalier Universitaire Rouen
Department of Plastic, Reconstructive and Aesthetic Surgery, and Hand Surgery
Rouen, France
Sponsor: Centre Hospitalier Universitaire Rouen
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.